Recurrent Neuroendocrine Carcinoma of the Skin
4 clinical trials · Condition
◉ Watch Recurrent Neuroendocrine Carcinoma of the Skin
| Record | Firm | Date |
|---|---|---|
| Temsirolimus and Vinorelbine Ditartrate in Treating Patients With Unresectable or Metastatic Solid Tumors (NCT01155258) | University of Southern California | 2010-06-01 |
| Everolimus and Vatalanib in Treating Patients With Advanced Solid Tumors (NCT00655655) | Mayo Clinic | 2004-12-01 |
| Oblimersen in Treating Patients With Merkel Cell Carcinoma (NCT00079131) | National Cancer Institute (NCI) | 2004-01-01 |
| S0331: Imatinib Mesylate in Treating Patients With Metastatic or Unresectable Merkel Cell Cancer (NCT00068783) | National Cancer Institute (NCI) | 2003-10-01 |
Track Recurrent Neuroendocrine Carcinoma of the Skin automatically
Every clearance here is in the API, with alerts when new ones post.